Active Substance |
Strength |
Form |
Ondansetron |
2mg/ml (Ampx4ml) |
Inj.Sol |
Palonosetron |
250mcg/5ml |
Inj.Sol |
Pantoprazole |
40mg/Vial |
Pd.Inj.Sol |
PosaconazoleUnder Development |
40 mg/mL |
Oral Suspension |
PosaconazoleUnder Development |
100mg/tab |
G.R. tabs |
PosaconazoleUnder Development |
300 mg |
C.So.In |
RemifentanilUnder Development |
1, 2 and 5 mg/vial |
Pd.C.So.In |
Simvastatin |
20mg, 40mg |
F.C.Tab |
Somatostatin |
3mg/Vial |
Ps.Sol.Inf |
Suggamadex |
100mg/ml |
Inj.Sol |
Tedizolid phosphateUnder Development |
200mg/tab |
F.C. Tabs |
Tedizolid phosphateUnder Development |
200mg |
Pd.C.So.In |
TeicoplaninUnder Development |
200 mg & 400 mg/vial |
Pd.Sol.Inf |
Tenoxicam |
20mg/Vial |
Ps.Inj.Sol |
Tenoxicam |
20mg |
F.C.Tab |
Tigecycline |
50mg/Vial |
Pd.Sol.Inf |
Vancomycin |
500mg/Vial |
Pd.Sol.Inf |
Vancomycin |
1g/vial |
Pd.Sol.Inf |
Vildagliptin/Metformin |
(50+850)mg/tab & (50+1000)mg/tab |
Tabs |
Voriconazole |
200mg/Vial |
Pd.Sol.Inf |
Products Search Results for ""
Active Substance |
Strength |
Form |
Ondansetron |
2mg/ml (Ampx4ml) |
Inj.Sol |
Palonosetron |
250mcg/5ml |
Inj.Sol |
Pantoprazole |
40mg/Vial |
Pd.Inj.Sol |
Posaconazole |
40 mg/mL |
Oral Suspension |
Posaconazole |
100mg/tab |
G.R. tabs |
Posaconazole |
300 mg |
C.So.In |
Remifentanil |
1, 2 and 5 mg/vial |
Pd.C.So.In |
Simvastatin |
20mg, 40mg |
F.C.Tab |
Somatostatin |
3mg/Vial |
Ps.Sol.Inf |
Suggamadex |
100mg/ml |
Inj.Sol |
Tedizolid phosphate |
200mg/tab |
F.C. Tabs |
Tedizolid phosphate |
200mg |
Pd.C.So.In |
Teicoplanin |
200 mg & 400 mg/vial |
Pd.Sol.Inf |
Tenoxicam |
20mg/Vial |
Ps.Inj.Sol |
Tenoxicam |
20mg |
F.C.Tab |
Tigecycline |
50mg/Vial |
Pd.Sol.Inf |
Vancomycin |
500mg/Vial |
Pd.Sol.Inf |
Vancomycin |
1g/vial |
Pd.Sol.Inf |
Vildagliptin/Metformin |
(50+850)mg/tab & (50+1000)mg/tab |
Tabs |
Voriconazole |
200mg/Vial |
Pd.Sol.Inf |
Active Substance |
Strength |
Form |
Market Availability |
Ondansetron |
2mg/ml (Ampx4ml) |
Inj.Sol |
Selected Markets |
Palonosetron |
250mcg/5ml |
Inj.Sol |
International |
Pantoprazole |
40mg/Vial |
Pd.Inj.Sol |
International |
PosaconazoleUnder Development |
40 mg/mL |
Oral Suspension |
TBC |
PosaconazoleUnder Development |
100mg/tab |
G.R. tabs |
TBC |
PosaconazoleUnder Development |
300 mg |
C.So.In |
Q1 / Q2 2025 |
RemifentanilUnder Development |
1, 2 and 5 mg/vial |
Pd.C.So.In |
Q2 2024 |
Simvastatin |
20mg, 40mg |
F.C.Tab |
Selected Markets |
Somatostatin |
3mg/Vial |
Ps.Sol.Inf |
International |
Suggamadex |
100mg/ml |
Inj.Sol |
International |
Tedizolid phosphateUnder Development |
200mg/tab |
F.C. Tabs |
TBC |
Tedizolid phosphateUnder Development |
200mg |
Pd.C.So.In |
TBC |
TeicoplaninUnder Development |
200 mg & 400 mg/vial |
Pd.Sol.Inf |
Q1 2023 |
Tenoxicam |
20mg/Vial |
Ps.Inj.Sol |
International |
Tenoxicam |
20mg |
F.C.Tab |
Selected Markets |
Tigecycline |
50mg/Vial |
Pd.Sol.Inf |
International |
Vancomycin |
500mg/Vial |
Pd.Sol.Inf |
International |
Vancomycin |
1g/vial |
Pd.Sol.Inf |
International |
Vildagliptin/Metformin |
(50+850)mg/tab & (50+1000)mg/tab |
Tabs |
International |
Voriconazole |
200mg/Vial |
Pd.Sol.Inf |
International |